Patients with advanced Chronic Obstructive Pulmonary Disease (COPD) are at increased risk of lung cancer, and should be screened with low-dose CT.
Unraveling the genome to reshape cancer care.
A partnership between the Fox Chase solid tumor oncologists and their colleagues in bone marrow transplantation tests the potential of adoptive cell therapies for the treatment of solid tumors.
Physicians at Temple Health have developed the Temple Healthy Chest Initiative to screen, diagnose, treat, and support patients who are at the greatest risk of developing lung cancer due to a history of smoking.
To further evaluate the use of immunotherapy for these patients with NSCLC, Treat is serving as a primary investigator in a nationwide Phase II, double-arm, randomized clinical trial of treatment-naïve never smokers without the EGFR driver ...
Join us in person or online for an international comprehensive educational symposium on chronic obstructive pulmonary disease (COPD). This is the seventh consecutive year for this one-day COPD conference. Wednesday, November 16, 2022 from 8:00 AM – 6:00 PM EST
Clinicians at Fox Chase Cancer Center are exploring how an established radiation technique—pulsed low-dose-rate radiation (PLDR)—might benefit patients with a variety of solid tumors.